Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

It’s not the first time the FDA has issued cybersecurity alerts about Medtronic products – in February last year a recall affected some of the company’s implantable defibrillators ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic Plc is a medical technology company ... The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Medtronic sells products in many end markets in these segments. It is usually the market leader or number two in each end market. Total revenue was more than $32.36 billion in fiscal year 2023 and ...

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...